Chadi Nabhan

5.1k total citations
139 papers, 1.9k citations indexed

About

Chadi Nabhan is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Chadi Nabhan has authored 139 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Pathology and Forensic Medicine, 66 papers in Genetics and 31 papers in Oncology. Recurrent topics in Chadi Nabhan's work include Lymphoma Diagnosis and Treatment (70 papers), Chronic Lymphocytic Leukemia Research (61 papers) and Viral-associated cancers and disorders (15 papers). Chadi Nabhan is often cited by papers focused on Lymphoma Diagnosis and Treatment (70 papers), Chronic Lymphocytic Leukemia Research (61 papers) and Viral-associated cancers and disorders (15 papers). Chadi Nabhan collaborates with scholars based in United States, United Kingdom and Australia. Chadi Nabhan's co-authors include Steven T. Rosen, Sonali M. Smith, Bruce A. Feinberg, Adam M. Petrich, Martin S. Tallman, Andrew M. Evens, Anthony R. Mato, Christopher R. Flowers, Neil E. Kay and Tait D. Shanafelt and has published in prestigious journals such as JAMA, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Chadi Nabhan

127 papers receiving 1.9k citations

Peers

Chadi Nabhan
Gerardo Musuraca Italy
Nishitha Reddy United States
Maura Brugiatelli Italy
Toby A. Eyre United Kingdom
G. Lepeu France
R. Gregory Bociek United States
Carla Casulo United States
Achiel Van Hoof Belgium
Joke W. Baars Netherlands
Monica Tani Italy
Gerardo Musuraca Italy
Chadi Nabhan
Citations per year, relative to Chadi Nabhan Chadi Nabhan (= 1×) peers Gerardo Musuraca

Countries citing papers authored by Chadi Nabhan

Since Specialization
Citations

This map shows the geographic impact of Chadi Nabhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chadi Nabhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chadi Nabhan more than expected).

Fields of papers citing papers by Chadi Nabhan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chadi Nabhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chadi Nabhan. The network helps show where Chadi Nabhan may publish in the future.

Co-authorship network of co-authors of Chadi Nabhan

This figure shows the co-authorship network connecting the top 25 collaborators of Chadi Nabhan. A scholar is included among the top collaborators of Chadi Nabhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chadi Nabhan. Chadi Nabhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Puri, Dhruv, Umang Swami, Georges Gebrael, et al.. (2024). PD09-05 DIFFERENCES IN GENOMIC, TRANSCRIPTOMIC AND IMMUNE LANDSCAPE OF PROSTATE CANCER (PCA) BASED ON SITE OF METASTASIS (METS). The Journal of Urology. 211(5S). 1 indexed citations
2.
Pan, Elizabeth, Andrew Elliott, Shankar Siva, et al.. (2024). Characterization of FOLH1 Expression in Renal Cell Carcinoma. Cancers. 16(10). 1855–1855. 1 indexed citations
3.
Bennett, Charles L., Antonio J. Trujillo, Kenneth R. Carson, et al.. (2024). Congressional Investigation of RevAssist-Linked and General Pricing Strategies for Lenalidomide. JCO Oncology Practice. 20(8). 1021–1026. 2 indexed citations
4.
Jia, Liwei, Margaret Meagher, Frederick Millard, et al.. (2024). Driver mutations associated with signatures of platinum sensitivity in germ cell tumors. npj Precision Oncology. 8(1). 249–249.
5.
Antonarakis, Emmanuel S., Shayan Nazari, Nicholas A. Zorko, et al.. (2024). The influence of the germline HSD3B1 adrenal-permissive variant (c.1100 C) on somatic alteration landscape, transcriptome, and immune-cell infiltration in prostate cancer.. Journal of Clinical Oncology. 42(4_suppl). 215–215. 1 indexed citations
6.
Stewart, Tyler F., Sarah E. Fenton, Shayan Nazari, et al.. (2024). Landscape analysis and oncologic outcomes in advanced urothelial carcinoma (UC) by NECTIN4 RNA expression.. Journal of Clinical Oncology. 42(16_suppl). 4585–4585. 1 indexed citations
7.
Nazha, Bassel, Sharon Wu, Jacqueline T. Brown, et al.. (2023). Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune‐checkpoint inhibitor‐related biomarkers. Cancer. 129(24). 3884–3893. 21 indexed citations
8.
Wei, Shuanzeng, Daniel M. Geynisman, Andrew Elliott, et al.. (2023). Molecular Characterization of TFE3-Rearranged Renal Cell Carcinoma: A Comparative Study With Papillary and Clear Cell Renal Cell Carcinomas. Modern Pathology. 37(2). 100404–100404. 7 indexed citations
9.
Cavalcante, Ludimila, Sachin Kumar Deshmukh, Jennifer R. Ribeiro, et al.. (2023). Opposing Roles of SPOP Mutations in Human Prostate and Endometrial Cancers. JCO Precision Oncology. 7(7). e2300088–e2300088. 4 indexed citations
10.
Mato, Anthony R., Chadi Nabhan, Neil E. Kay, et al.. (2017). Prognostic Testing Patterns and Outcomes of Chronic Lymphocytic Leukemia Patients Stratified by Fluorescence In Situ Hybridization/Cytogenetics: A Real-world Clinical Experience in the Connect CLL Registry. Clinical Lymphoma Myeloma & Leukemia. 18(2). 114–124.e2. 24 indexed citations
11.
12.
Nabhan, Chadi & Anthony R. Mato. (2017). Emerging Strategies in Treating Double Hit Lymphomas. Clinical Lymphoma Myeloma & Leukemia. 17(9). 563–568. 4 indexed citations
13.
Foster, Jared C., Drew K. Seisler, Jacqueline M. Lafky, et al.. (2016). Toxicities and Related Outcomes of Elderly Patients (pts) (≥65 Years) with Hematologic Malignancies in the Contemporary Era (Alliance A151611). Blood. 128(22). 536–536.
14.
Nabhan, Chadi, Michelle Byrtek, Ashish Rai, et al.. (2015). Disease characteristics, treatment patterns, prognosis, outcomes and lymphoma‐related mortality in elderly follicular lymphoma in the United States. British Journal of Haematology. 170(1). 85–95. 50 indexed citations
15.
16.
Evens, Andrew M., Irene Helenowski, Chadi Nabhan, et al.. (2011). Multicenter Analysis of Elderly Hodgkin Lymphoma (eHL): Outcomes and Prognostic Factors in the Modern Era. Blood. 118(21). 2625–2625.
17.
Nabhan, Chadi, Neil Dalal, Jayesh Mehta, & Neil E. Kay. (2011). Biologic agent activity in chronic lymphocytic leukemia: a framework for future therapies. Leukemia & lymphoma. 52(3). 374–386. 1 indexed citations
18.
Nabhan, Chadi, Steven Coutré, & Peter Hillmen. (2006). Minimal residual disease in chronic lymphocytic leukaemia: is it ready for primetime?. British Journal of Haematology. 136(3). 379–392. 17 indexed citations
19.
Kwaan, Hau C. & Chadi Nabhan. (2003). Hereditary and acquired defects in the fibrinolytic system associated with thrombosis. Hematology/Oncology Clinics of North America. 17(1). 103–114. 9 indexed citations
20.
Nabhan, Chadi, Lo Ann C. Peterson, Martin S. Tallman, et al.. (2002). Secondary Acute Myelogenous Leukemia with MLL Gene Rearrangement Following Radioimmunotherapy (RAIT) for Non-Hodgkin's Lymphoma. Leukemia & lymphoma. 43(11). 2145–2149. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gerardo Musuraca Breakdown of academic impact, for papers by Nishitha Reddy Breakdown of academic impact, for papers by Maura Brugiatelli Breakdown of academic impact, for papers by Toby A. Eyre Breakdown of academic impact, for papers by G. Lepeu Breakdown of academic impact, for papers by R. Gregory Bociek Breakdown of academic impact, for papers by Carla Casulo Breakdown of academic impact, for papers by Achiel Van Hoof Breakdown of academic impact, for papers by Joke W. Baars Breakdown of academic impact, for papers by Monica Tani
Rankless by CCL
2026